EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

医学 类风湿性关节炎 抗风湿药物 关节炎 羟基氯喹 抗风湿药 内科学 生物药物 免疫学 重症监护医学 疾病 传染病(医学专业) 2019年冠状病毒病(COVID-19)
作者
Josef S Smolen,Robert Landewé,J. W. J. Bijlsma,Gerd Burmester,Katerina Chatzidionysiou,Maxime Dougados,Jackie Nam,Sofía Ramiro,Marieke Voshaar,Ronald van Vollenhoven,Daniel Aletaha,Aringer Martin,Maarten Boers,Chris D Buckley,Frank Buttgereit,Vivian Bykerk,Mario Humberto Cardiel,Bernard G Combe,Maurizio Cutolo,Yvonne van Eijk‐Hustings
出处
期刊:Annals of the Rheumatic Diseases [BMJ]
卷期号:76 (1): 3-18 被引量:7711
标识
DOI:10.1136/ard-2022-223356
摘要

Objectives

To provide an update of the EULAR rheumatoid arthritis (RA) management recommendations addressing the most recent developments in the field.

Methods

An international task force was formed and solicited three systematic literature research activities on safety and efficacy of disease-modifying antirheumatic drugs (DMARDs) and glucocorticoids (GCs). The new evidence was discussed in light of the last update from 2019. A predefined voting process was applied to each overarching principle and recommendation. Levels of evidence and strengths of recommendation were assigned to and participants finally voted on the level of agreement with each item.

Results

The task force agreed on 5 overarching principles and 11 recommendations concerning use of conventional synthetic (cs) DMARDs (methotrexate (MTX), leflunomide, sulfasalazine); GCs; biological (b) DMARDs (tumour necrosis factor inhibitors (adalimumab, certolizumab pegol, etanercept, golimumab, infliximab including biosimilars), abatacept, rituximab, tocilizumab, sarilumab and targeted synthetic (ts) DMARDs, namely the Janus kinase inhibitors tofacitinib, baricitinib, filgotinib, upadacitinib. Guidance on monotherapy, combination therapy, treatment strategies (treat-to-target) and tapering in sustained clinical remission is provided. Safety aspects, including risk of major cardiovascular events (MACEs) and malignancies, costs and sequencing of b/tsDMARDs were all considered. Initially, MTX plus GCs is recommended and on insufficient response to this therapy within 3–6 months, treatment should be based on stratification according to risk factors; With poor prognostic factors (presence of autoantibodies, high disease activity, early erosions or failure of two csDMARDs), any bDMARD should be added to the csDMARD; after careful consideration of risks of MACEs, malignancies and/or thromboembolic events tsDMARDs may also be considered in this phase. If the first bDMARD (or tsDMARD) fails, any other bDMARD (from another or the same class) or tsDMARD (considering risks) is recommended. With sustained remission, DMARDs may be tapered but should not be stopped. Levels of evidence and levels of agreement were high for most recommendations.

Conclusions

These updated EULAR recommendations provide consensus on RA management including safety, effectiveness and cost.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
rongjie发布了新的文献求助10
刚刚
muyouwifi发布了新的文献求助10
刚刚
FashionBoy的应助被优美的未来采纳,获得10
1秒前
小蘑菇的应助被111采纳,获得10
1秒前
1秒前
Hello的应助被一杯芝士采纳,获得10
1秒前
今后的应助被CQNU破产之人采纳,获得10
2秒前
Orange的应助被szxa采纳,获得10
2秒前
Free完成签到,获得积分20
2秒前
sx发布了新的文献求助10
2秒前
小宋完成签到 ,获得积分10
2秒前
纯真大象发布了新的文献求助10
4秒前
zxd发布了新的文献求助10
4秒前
5秒前
会相遇完成签到,获得积分10
5秒前
xyl完成签到,获得积分10
5秒前
549发布了新的文献求助10
5秒前
6秒前
HYYY完成签到,获得积分10
6秒前
firework完成签到,获得积分10
7秒前
Qiiii完成签到,获得积分10
8秒前
科研通AI6.3的应助被阿鹏采纳,获得10
10秒前
WU_JIABIN发布了新的文献求助10
11秒前
科研通AI6.2的应助被Liy采纳,获得10
13秒前
单薄幻梦发布了新的文献求助10
13秒前
13秒前
14秒前
田様的应助被无敌小宝贝采纳,获得10
14秒前
夏安完成签到,获得积分10
15秒前
15秒前
qin202569发布了新的文献求助10
16秒前
CodeCraft的应助被纯真大象采纳,获得10
16秒前
16秒前
17秒前
二娃发布了新的文献求助10
17秒前
南瓜完成签到,获得积分10
17秒前
努力小人完成签到,获得积分10
17秒前
NexusExplorer的应助被NPC-CBI采纳,获得10
18秒前
开心盼海发布了新的文献求助10
19秒前
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8178960
求助须知:如何正确求助?哪些是违规求助? 9569638
关于积分的说明 21805682
捐赠科研通 7774071
什么是DOI,文献DOI怎么找? 3432955
关于科研通互助平台的介绍 2556897
邀请新用户注册赠送积分活动 2478640